Cargando…

Heterogeneity at the invasion front of triple negative breast cancer cells

Identifying better predictive and prognostic biomarkers for the diagnosis and treatment of triple negative breast cancer (TNBC) is complicated by tumor heterogeneity ranging from responses to therapy, mutational burden, and clonal evolution. To overcome the gap in our understanding of tumor heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aw Yong, Koh Meng, Ulintz, Peter J., Caceres, Sara, Cheng, Xu, Bao, Liwei, Wu, Zhifen, Jiagge, Evelyn M., Merajver, Sofia D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113246/ https://www.ncbi.nlm.nih.gov/pubmed/32238832 http://dx.doi.org/10.1038/s41598-020-62516-8

Ejemplares similares

Tracking the tumor invasion front using long-term fluidic tumoroid culture
por: Aw Yong, Koh Meng, et al.
Publicado: (2017)

RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers
por: Abraham, Hannah G., et al.
Publicado: (2021)

RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells
por: Rosenthal, Devin T., et al.
Publicado: (2012)

IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling
por: Little, Andrew C., et al.
Publicado: (2019)

Breast Cancer in Ghana: Demonstrating the Need for Population-Based Cancer Registries in Low- and Middle-Income Countries
por: Thomas, Abigail S., et al.
Publicado: (2017)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman, Michael L, et al.
Publicado: (2015)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
por: Bartelink, Imke H., et al.
Publicado: (2017)

The heterogeneity of cancer stem-like cells at the invasive front
por: Yoshida, Go J.
Publicado: (2017)

Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?
por: Kaplan, Mark H., et al.
Publicado: (2020)

Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer
por: Chiu, Alec M., et al.
Publicado: (2018)

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
por: Jiang, Lin, et al.
Publicado: (2022)

Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
por: Kudelova, Eva, et al.
Publicado: (2022)

Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana
por: Merz, Lauren E., et al.
Publicado: (2019)

Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity
por: Kvokačková, Barbora, et al.
Publicado: (2021)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
por: Mahmoud, Rinad, et al.
Publicado: (2022)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Genomic regulation of invasion by STAT3 in triple negative breast cancer
por: McDaniel, Joy M., et al.
Publicado: (2016)

Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics
por: Chen, Weiqiang, et al.
Publicado: (2016)

Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines
por: Alonso-Diez, Ángela, et al.
Publicado: (2021)

Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
por: Yuan, Yinyin
Publicado: (2015)

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
por: Bareche, Y, et al.
Publicado: (2018)

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
por: Romero-Cordoba, Sandra, et al.
Publicado: (2019)

Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
por: Martini, Rachel, et al.
Publicado: (2021)

Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma
por: Sflomos, George, et al.
Publicado: (2023)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery
por: Ahn, Ki Jung, et al.
Publicado: (2017)

Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1
por: Gonzalez, Maria E., et al.
Publicado: (2008)

Triple‐negative breast carcinomas are a heterogeneous entity that differs between young and old patients
por: Carvalho, Filomena M, et al.
Publicado: (2010)

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
por: Bareche, Yacine, et al.
Publicado: (2019)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
por: Jiang, Ke, et al.
Publicado: (2021)

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers
por: Liu, Yiduo, et al.
Publicado: (2021)

Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery
por: van der Noord, Vera E., et al.
Publicado: (2022)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
por: Hu, Xi′e, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e5kocvsa57uo7gcdmcp7t9bt5k